Identification and Validation of the Common Pathogenesis and Hub Biomarkers in Hirschsprung Disease Complicated with Crohn's Disease

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Oct 17

PMID 36248794

Authors

Jing Wang

Zejian Li

Jun Xiao

Luyao Wu

Ke Chen

Tianqi Zhu

Chenzhao Feng

Didi Zhuansun

Xinyao Meng

Jiexiong Feng

Affiliations

Soon will be listed here.

Abstract

Background: Although increasing evidence has supported that Hirschsprung disease (HSCR) is the risk factor for children developing Crohn's disease (CD), the common mechanism of its co-occurrence remains unknown. The purpose of this study is to further explore the underlying mechanism and biomarkers for the co-occurrence of HSCR and CD.

Methods: The Gene Expression Omnibus (GEO) database was used to obtain gene expression profiles for CD (GSE95095) and HSCR (GSE98502). Following the identification of the shared differentially expressed genes (DEGs) of CD and HSCR, functional annotation, protein-protein interaction (PPI) network creation, and module assembly were performed to discover hub genes. RT-qPCR was performed to validate the expression of the hub genes in HSCR samples. The receiver operating characteristic (ROC) curve was utilized to assess the accuracy of the hub genes as biomarkers in predicting CD in both the training dataset and test dataset.

Results: A total of 103 common DEGs (50 downregulated genes and 53 upregulated genes) were chosen for further investigation. The importance of chemokines and cytokines in these two disorders is highlighted by functional analysis. MCODE plug identified three important modules, which functionally enriched the immune system process. Finally, nine hub genes were identified using cytoHubba, including IL1B, IL10, CXCL10, ICAM1, EGR1, FCGR3A, S100A12, S100A9, and FPR1. The nine hub genes were mainly enriched in immune- and inflammation-related pathways. External data profiles and RT-qPCR confirmed the expression of the nine hub genes in HSCR and CD. ROC analysis revealed that the nine hub genes had a strong diagnostic value.

Conclusion: Our study reveals the common pathogenesis of HSCR and CD. These hub genes and diagnostic models may provide novel insight for the diagnosis and treatment of HSCR complicated with CD.

Citing Articles

Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.

Liu Y, Kong X, Sun Q, Cui T, Xu S, Ding C PLoS One. 2025; 20(3):e0317369.

PMID: 40063597 PMC: 11892850. DOI: 10.1371/journal.pone.0317369.

Bioinformatics Prediction for Network-Based Integrative Multi-Omics Expression Data Analysis in Hirschsprung Disease.

Lucena-Padros H, Bravo-Gil N, Tous C, Rojano E, Seoane-Zonjic P, Fernandez R Biomolecules. 2024; 14(2).

PMID: 38397401 PMC: 10886964. DOI: 10.3390/biom14020164.

A unicentric cross-sectional observational study on chronic intestinal inflammation in total colonic aganglionosis: beware of an underestimated condition.

Erculiani M, Poluzzi F, Mottadelli G, Felici E, Ml N, Caraccia M Orphanet J Rare Dis. 2023; 18(1):339.

PMID: 37891621 PMC: 10612252. DOI: 10.1186/s13023-023-02958-1.

References

Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz L, Smart C . Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology. 1991; 100(1):150-9. DOI: 10.1016/0016-5085(91)90595-c. View

Thiel G, Cibelli G . Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol. 2002; 193(3):287-92. DOI: 10.1002/jcp.10178. View

Ternant D, Berkane Z, Picon L, Gouilleux-Gruart V, Colombel J, Allez M . Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn's Disease. Clin Pharmacokinet. 2014; 54(5):551-62. DOI: 10.1007/s40262-014-0225-3. View

Frykman P, Nordenskjold A, Kawaguchi A, Hui T, Granstrom A, Cheng Z . Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study. PLoS One. 2015; 10(4):e0124172. PMC: 4409062. DOI: 10.1371/journal.pone.0124172. View

Wang J, Xiao J, Meng X, Chu X, Zhuansun D, Xiong B . NOX5 is expressed aberrantly but not a critical pathogenetic gene in Hirschsprung disease. BMC Pediatr. 2021; 21(1):153. PMC: 8008622. DOI: 10.1186/s12887-021-02611-5. View

Mak W, Zhao M, Ng S, Burisch J . The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2019; 35(3):380-389. DOI: 10.1111/jgh.14872. View

Chen X, Zhang H, Li N, Feng J . Pathological changes of interstitial cells of Cajal and ganglion cells in the segment of resected bowel in Hirschsprung's disease. Pediatr Surg Int. 2016; 32(11):1019-1024. DOI: 10.1007/s00383-016-3961-7. View

Lof Granstrom A, Amin L, Arnell H, Wester T . Increased Risk of Inflammatory Bowel Disease in a Population-based Cohort Study of Patients With Hirschsprung Disease. J Pediatr Gastroenterol Nutr. 2017; 66(3):398-401. DOI: 10.1097/MPG.0000000000001732. View

Bacher P, Scheffold A . The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy. J Allergy Clin Immunol. 2018; 142(6):1697-1709. DOI: 10.1016/j.jaci.2018.10.016. View

10.

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

11.

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View

12.

SHERMAN J, Snyder M, WEITZMAN J, Jona J, GILLIS D, ODonnell B . A 40-year multinational retrospective study of 880 Swenson procedures. J Pediatr Surg. 1989; 24(8):833-8. DOI: 10.1016/s0022-3468(89)80548-2. View

13.

Smoot M, Ono K, Ruscheinski J, Wang P, Ideker T . Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2010; 27(3):431-2. PMC: 3031041. DOI: 10.1093/bioinformatics/btq675. View

14.

Leach S, Yang Z, Messina I, Song C, Geczy C, Cunningham A . Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007; 42(11):1321-31. DOI: 10.1080/00365520701416709. View

15.

Nakamura H, Lim T, Puri P . Inflammatory bowel disease in patients with Hirschsprung's disease: a systematic review and meta-analysis. Pediatr Surg Int. 2017; 34(2):149-154. DOI: 10.1007/s00383-017-4182-4. View

16.

Bernstein C, Kuenzig M, Coward S, Nugent Z, Nasr A, El-Matary W . Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study. J Pediatr. 2021; 233:98-104.e2. DOI: 10.1016/j.jpeds.2021.01.060. View

17.

Kopi T, Kadijani A, Parsian H, Shahrokh S, Aghdaei H, Mirzaei A . The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease. Arab J Gastroenterol. 2019; 20(3):135-140. DOI: 10.1016/j.ajg.2019.07.002. View

18.

Guan Q, Zhang J . Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm. 2017; 2017:4810258. PMC: 5379128. DOI: 10.1155/2017/4810258. View

19.

Lof Granstrom A, Ludvigsson J, Wester T . Clinical characteristics and validation of diagnosis in individuals with Hirschsprung disease and inflammatory bowel disease. J Pediatr Surg. 2020; 56(10):1799-1802. DOI: 10.1016/j.jpedsurg.2020.11.015. View

20.

Lopez R, Leach S, Lemberg D, Duvoisin G, Gearry R, Day A . Fecal biomarkers in inflammatory bowel disease. J Gastroenterol Hepatol. 2016; 32(3):577-582. DOI: 10.1111/jgh.13611. View